|
|
Home >
Anti-aging Research > MitoQ.
MitoQ
Specific Recommendations:
News & Research:
-
Novel
antioxidant makes old blood vessels seem young again - Science Daily,
4/19/18 - "Half took 20 milligrams per day of a supplement called MitoQ, made by
chemically altering the naturally-occurring antioxidant Coenzyme Q10 to make it
cling to mitochondria inside cells ... The other half took a placebo ... The
researchers found that when taking the supplement, dilation of subjects'
arteries improved by 42 percent, making their blood vessels, at least by that
measure, look like those of someone 15 to 20 years younger. An improvement of
that magnitude, if sustained, is associated with about a 13 percent reduction in
heart disease, Rossman said. The study also showed that the improvement in
dilation was due to a reduction in oxidative stress" - See
MitoQ at Amazon.com.
-
Common
antioxidant could slow symptoms of aging in human skin - Science Daily,
5/30/17 - "The effects we are seeing are not temporary.
Methylene blue appears to make fundamental, long-term changes to skin cells ...
In addition to methylene blue, the researchers also tested three other known
antioxidants: N-Acetyl-L-Cysteine (NAC), MitoQ and MitoTEMPO (mTEM) ... In these
experiments, methylene blue outperformed the other three antioxidants, improving
several age-related symptoms in cells from both healthy donors and progeria
patients. The skin cells (fibroblasts, the cells that produce the structural
protein collagen) experienced a decrease in damaging molecules known as reactive
oxygen species, a reduced rate of cell death and an increase in the rate of cell
division throughout the four-week treatment" - Note: The problem is
that methylene blue isn't available to purchase anywhere. The other three
(N-Acetyl-L-Cysteine (NAC), MitoQ and MitoTEMPO (mTEM))
are. See
MitoQ at Amazon.com.
-
Novel
antioxidant makes old arteries seem young again, study shows - Science
Daily, 5/6/14 - "When the research team gave old mice -- the equivalent of 70-
to 80-year-old humans -- water containing an antioxidant known as MitoQ for four
weeks, their arteries functioned as well as the arteries of mice with an
equivalent human age of just 25 to 35 years ... MitoQ completely restored
endothelial function in the old mice. They looked like young mice ...
Biochemists manufactured MitoQ by adding a molecule to ubiquinone (also known as
coenzyme Q10), a naturally occurring antioxidant. The additional molecule makes
the ubiquinone become concentrated in mitochondria ... the MitoQ treatment
increased levels of nitric oxide, reduced oxidative stress and improved the
health of the mitochondria in the arteries of old mice" - See MitoQ at Amazon.com.
-
Antioxidant drug knocks down multiple sclerosis-like disease in mice -
Science Daily, 12/26/13 - "The antioxidant -- called
MitoQ -- has shown some promise in fighting neurodegenerative diseases. But
this is the first time it has been shown to significantly reverse an MS-like
disease in an animal ... the researchers induced mice to contract a disease
called experimental autoimmune encephalomyelitis, or EAE, which is very
similar to MS in humans ... After 14 days, the EAE mice that had been
treated with the MitoQ exhibited reduced inflammatory markers and increased
neuronal activity in the spinal cord -- an affected brain region in MS --
that showed their EAE symptoms were being improved by the treatment. The
mice also showed reduced loss of axons, or nerve fibers and reduced
neurological disabilities associated with the EAE. The mice that had been
pre-treated with the MitoQ showed the least problems. The mice that had been
treated with MitoQ after EAE also showed many fewer problems than mice who
were just induced to get the EAE and then given no treatment"
- MitoQ - Wikipedia -
"The active antioxidant component of MitoQ is
ubiquinone, which is identical to the active antioxidant in Coenzyme
Q10" - See
ubiquinol products at Amazon.com.
-
Antioxidant has potential in the Alzheimer's fight - Science Daily,
12/14/11 - "When you cut an apple and leave it out,
it turns brown. Squeeze the apple with lemon juice, an antioxidant, and the
process slows down ... Simply put, that same "browning" process-known as
oxidative stress-happens in the brain as Alzheimer's disease sets in ... an
antioxidant can delay the onset of all the indicators of Alzheimer's
disease, including cognitive decline. The researchers administered an
antioxidant compound called MitoQ to mice genetically engineered to develop
Alzheimer's. The results of their study were published in the Nov. 2 issue
of the Journal of Neuroscience ... Oxidative stress is believed to cause
neurons in the brain to die, resulting in Alzheimer's ... The brain consumes
20 percent of the oxygen in the body even though it only makes up 5 percent
of the volume, so it's particularly susceptible to oxidative stress ...
MitoQ selectively accumulates in the mitochondria" - Note: I
couldn't find the ingredients but it sounds like a form of co-enzyme Q10.
Here's the form I take:
ubiquinol products at Amazon.com
Abstracts:
-
Mitochondria-targeted antioxidant supplementation improves 8 km time trial
performance in middle-aged trained male cyclists - Journal of the
International Society of Sports Nutrition volume 18, Article number: 58 (2021) -
"19 middle-aged (age: 44 ± 4 years) recreationally
trained (VO2peak: 58.5 ± 6.2 ml·kg− 1·min− 1, distance cycled per week during 6
months prior to study enrollment: 158.3 ± 58.4 km) male cyclists completed
45 min cycling at 70% VO2peak followed by an 8 km time trial after 28 days of
supplementation with MitoQ (20 mg·day− 1) and a placebo ... Mean completion time
for the time trial was 1.3% faster with MitoQ (12.91 ± 0.94 min) compared to
placebo (13.09 ... These data suggest that MitoQ supplementation may be an
effective nutritional strategy to attenuate exercise-induced increases in
oxidative damage to lipids and improve cycling performance" - [Nutra
USA] - See
MitoQ at Amazon.com.
-
The targeted
anti‐oxidant MitoQ causes mitochondrial swelling and depolarization in kidney
tissue - Physiol Rep. 2018 Apr; 6(7): e13667 - "In
summary, MitoQ causes mitochondrial swelling and depolarization in PT cells by a
mechanism unrelated to anti‐oxidant activity, most likely because of increased
IMM permeability due to insertion of the alkyl chain"
-
Combined
therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and
angiotensin receptor blocker, losartan, on cardiovascular function - J
Hypertens. 2013 Dec 4 - "Eight-week-old male
stroke-prone spontaneously hypertensive rats (SHRSPs, n=8-11) were treated with
low-dose losartan (2.5mg/kg per day); MitoQ10 (500μmol/l); a combination of
MitoQ10 and losartan (M+L); or vehicle for 8 weeks. Systolic pressure and pulse
pressure were significantly lower in M+L rats (167.1±2.9mmHg; 50.2±2.05mmHg)
than in untreated SHRSP (206.6±9mmHg, P<0.001; 63.7±2.7mmHg, P=0.001) and
demonstrated greater improvement than MitoQ10 or low-dose losartan alone, as
measured by radiotelemetry. Left ventricular mass index was significantly
reduced from 22.8±0.74 to 20.1±0.61mg/mm in the combination group"
|
|